Immediate Impact
1 by Nobel laureates 64 standout
Citing Papers
Cancer statistics, 2024
2024 Standout
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
2024 Standout
Works of Pernelle Lavaud being referenced
1215O - SC Neoadjuvant atezolizumab (A) for resectable non-small cell lung cancer (NSCLC): Results from the phase II PRINCEPS trial
2020
Atézolizumab (Tecentriq ® ) : activité, indication et modalités d’utilisation dans les carcinomes urothéliaux localement avancés ou métastatiques
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Pernelle Lavaud | 361 | 275 | 73 | 90 | 68 | 518 | |
| Mikihiro Kohno | 327 | 298 | 87 | 139 | 65 | 615 | |
| Giulia Mazzaschi | 424 | 244 | 91 | 122 | 53 | 594 | |
| Joshua E. Reuss | 354 | 241 | 38 | 114 | 52 | 494 | |
| M-J. Ahn | 503 | 381 | 89 | 113 | 67 | 598 | |
| Xavier González | 263 | 377 | 76 | 75 | 73 | 649 | |
| Elaine Shum | 364 | 321 | 64 | 165 | 51 | 536 | |
| María Gión | 457 | 284 | 91 | 115 | 66 | 614 | |
| Hui Yu | 407 | 349 | 74 | 136 | 40 | 576 | |
| Yasuhiro Chikaishi | 313 | 285 | 77 | 144 | 60 | 589 | |
| Taiji Kuwata | 316 | 356 | 49 | 61 | 72 | 617 |
All Works
Login with ORCID to disown or claim papers
Loading papers...